Homepage
Medication Guide
Instructions for Selumetinib: action and efficacy, dosage, side effects, precautions
Selumetinib is a MEK1/2 inhibitor developed by AstraZeneca and approved by the US FDA in April 2020 for the treatment of neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas in child...
506
Tuesday, June 24th, 2025, 17:29
Side effects of Selumetinib
Selumetinib is a MEK1/2 inhibitor that has shown promising efficacy in the treatment of neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas, but also comes with a specific risk of s...
508
Tuesday, June 24th, 2025, 17:22
Adverse reactions caused by Selumetinib bisulfate capsules
The U.S. FDA Approved Selumetinib (Koselugo) for the Treatment of Pediatric Patients 2 years of age and older with Neurofibromatosis Type 1 (NF1) and Symptomatic, Inoperable Plexiform Neurofibromas (P...
506
Tuesday, June 24th, 2025, 17:12
Selumetinib side effects
Selumetinib is a targeted drug for the treatment of neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas, which may also bring a series of side effects. Mastering the correct mitigat...
508
Tuesday, June 24th, 2025, 17:00
Adverse effects of Selumetinib
As a highly effective tyrosine kinase inhibitor, Selumetinib has shown significant anti-lesion effect in clinical treatment, bringing new hope to many patients with lesions. As with many potent d...
508
Tuesday, June 24th, 2025, 16:56
Selumetinib dosage
Selumetinib(Koselugo) has demonstrated significant clinical efficacy as a kinase inhibitor in pediatric patients with neurofibromatosis type 1 (NF1) who are 2 years of age and older with symptomatic, ...
508
Tuesday, June 24th, 2025, 16:51
Selumetinib effect
Selumetinib is a targeted therapy drug that is primarily used to treat specific types of neurofibromatosis. This article will delve into the mechanism of action of Selumetinib, its clinical efficacy, ...
504
Tuesday, June 24th, 2025, 16:45
Efficacy of Selumetinib
Selumetinib is a targeted drug specifically designed for the treatment of neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas (PN). This article will detail the efficacy of Selumetinib, ...
507
Tuesday, June 24th, 2025, 16:13
Is Selumetinib a targeted drug?
Selumetinib is a targeted therapy that specifically targets specific genetic mutations, primarily for the treatment of plexiform neurofibromas associated with neurofibromatosis type 1. This artic...
508
Tuesday, June 24th, 2025, 15:37
What kind of drug is Selumetinib?
Selumetinib is a targeted therapy that specifically targets specific types of neurofibromatosis. This article will introduce the basic information, dosage, and precautions of Selumetinib in ...
508
Tuesday, June 24th, 2025, 15:11
197 / 208
2075 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved